These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27125084)

  • 41. Profiles of Inflammatory Cytokines in the Vitreous Fluid from Patients with Rhegmatogenous Retinal Detachment and Their Correlations with Clinical Features.
    Takahashi S; Adachi K; Suzuki Y; Maeno A; Nakazawa M
    Biomed Res Int; 2016; 2016():4256183. PubMed ID: 28074184
    [No Abstract]   [Full Text] [Related]  

  • 42. Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy.
    Symeonidis C; Androudi S; Georgalas I; Tzamalis A; Chalvatzis N; Rotsos T; Souliou E; Diza E; Dimitrakos SA
    Clin Exp Immunol; 2015 Aug; 181(2):338-42. PubMed ID: 25766782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thrombin Generation in Vitreous and Subretinal Fluid of Patients with Retinal Detachment.
    Mulder VC; Bastiaans J; van Leuven CJM; van Meurs JC; Kluft C
    Ophthalmologica; 2018; 240(1):23-28. PubMed ID: 29617690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Profibrotic cytokines in aqueous humour correlate with aqueous flare in patients with rhegmatogenous retinal detachment.
    Hoerster R; Hermann MM; Rosentreter A; Muether PS; Kirchhof B; Fauser S
    Br J Ophthalmol; 2013 Apr; 97(4):450-3. PubMed ID: 23355528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy.
    El-Asrar AM; Nawaz MI; Kangave D; Geboes K; Ola MS; Ahmad S; Al-Shabrawey M
    Mol Vis; 2011; 17():1829-38. PubMed ID: 21850157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders.
    Banerjee S; Savant V; Scott RA; Curnow SJ; Wallace GR; Murray PI
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2203-7. PubMed ID: 17460280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment.
    Kenarova B; Voinov L; Apostolov C; Vladimirova R; Misheva A
    Eur J Ophthalmol; 1997; 7(1):64-7. PubMed ID: 9101198
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy.
    Limb GA; Chignell AH
    Br J Ophthalmol; 1999 Aug; 83(8):953-6. PubMed ID: 10413701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of systemic renin-angiotensin-inhibition on ocular cytokines related to proliferative vitreoretinopathy.
    Hoerster R; Fauser S; Cursiefen C; Kirchhof B; Heindl LM
    Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1721-1725. PubMed ID: 28600710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
    Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
    Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous.
    Mysore Y; Del Amo EM; Loukovaara S; Hagström M; Urtti A; Kauppinen A
    Sci Rep; 2021 Jan; 11(1):980. PubMed ID: 33441813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathological vitreous causes cell line-derived (but not donor-derived) retinal pigment epithelial cells to display proliferative vitreoretinopathy-like features in culture.
    Sharma M; Tiwari A; Sharma S; Bansal R; Gupta V; Gupta A; Luthra-Guptasarma M
    Clin Exp Ophthalmol; 2014 Nov; 42(8):745-60. PubMed ID: 24612444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postoperative aqueous humour flare as a surrogate marker for proliferative vitreoretinopathy development.
    Mulder VC; van Dijk EHC; van Meurs IA; La Heij EC; van Meurs JC
    Acta Ophthalmol; 2018 Mar; 96(2):192-196. PubMed ID: 29068530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. THE PATHOGENY OF PROLIFERATIVE VITREORETINOPATHY.
    Ciprian D
    Rom J Ophthalmol; 2015; 59(2):88-92. PubMed ID: 26978867
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitreous Cytokine Expression and a Murine Model Suggest a Key Role of Microglia in the Inflammatory Response to Retinal Detachment.
    Kiang L; Ross BX; Yao J; Shanmugam S; Andrews CA; Hansen S; Besirli CG; Zacks DN; Abcouwer SF
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3767-3778. PubMed ID: 30046818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment.
    Dai Y; Wu Z; Sheng H; Zhang Z; Yu M; Zhang Q
    Mol Vis; 2015; 21():417-27. PubMed ID: 26015767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders.
    Cassidy L; Barry P; Shaw C; Duffy J; Kennedy S
    Br J Ophthalmol; 1998 Feb; 82(2):181-5. PubMed ID: 9613386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of interleukin IL-6 levels in the subretinal fluid and the vitreous during rhegmatogenous retinal detachment.
    Symeonidis C; Androudi S; Tsaousis KT; Tsinopoulos I; Brazitikos P; Diza E; Dimitrakos SA
    Cytokine; 2012 Jan; 57(1):17-8. PubMed ID: 22070971
    [No Abstract]   [Full Text] [Related]  

  • 60. Statins in rhegmatogenous retinal detachment are associated with low intravitreal angiopoietin-2, VEGF and MMP-2 levels, and improved visual acuity gain in vitrectomized patients.
    Tuuminen R; Haukka J; Loukovaara S
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1685-93. PubMed ID: 25432094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.